Clinical success rate of mineral trioxide aggregate pulpotomy in primary teeth
Message:
Abstract:
Background And Aim
Formocresol (FC) is yet, the most common medication used for pulpotomy of primary teeth. However, its potential hazards including toxicity, mutagenicity and even some degrees of carcinogenicity are the remaining sources of concern to clinicians. This investigation was aimed at comparing the clinical success level of MTA (case) treated pulps of primary teeth to that of Formocresol (control).
Materials and Methods
A group of 17 children aged 4-9 years were selected from those attended Shahid Beheshti, Dental School. Each case was served as case and control (for a matched paired teeth plan). Pre and post operative X-ray (PA or BW) were also obtained in intervals of immediately before, and 6 months after the treatment associated with through clinical assessment of each tooth using clinical soundness criterias. Collected data were analyzed using Mc Nemar test.
Results
In total, 40 primary teeth (22 second primary molars and 18 First primary molars) were included in this trial. Statistical analysis of the data revealed no significant difference between clinical or radiographic observation of the groups in 6 month control stage. There was, however, a significant difference between the two groups for their furcation lesions being seen with a higher rate in the case of formocresol treated (control) group in 6 month follow up stage (P=0.047).
Conclusion
It seems that clinical and radiographic success level of MTA is as acceptable as formocresol giving the suggestion of its potential replacement for a safer pulp treatment of primary teeth.
Language:
Persian
Published:
Journal of Dental School, Volume:26 Issue: 3, 2009
Page:
274
magiran.com/p599423  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 990,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 50 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!